WG
MRNA icon

Winton Group’s Moderna MRNA Stock Holding History

Winton Group’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-27,144
Closed -$800K – 1295
2025
Q4 		$800K Buy
+27,144
New +$737K 0.03% 535
2025
Q1 		– Sell
-18,516
Closed -$770K – 749
2024
Q4 		$770K Buy
+18,516
New +$885K 0.05% 396
2024
Q3 		– Sell
-3,584
Closed -$426K – 724
2024
Q2 		$426K Buy
+3,584
New +$454K 0.03% 443
2023
Q4 		– Sell
-3,270
Closed -$338K – 821
2023
Q3 		$338K Buy
3,270
+851
+35% +$94.9K 0.03% 505
2023
Q2 		$294K Sell
2,419
-5,099
-68% -$680K 0.02% 533
2023
Q1 		$1.15M Sell
7,518
-3,256
-30% -$537K 0.07% 392
2022
Q4 		$1.94M Sell
10,774
-29,228
-73% -$4.78M 0.13% 210
2022
Q3 		$4.73M Buy
40,002
+3,869
+11% +$587K 0.31% 52
2022
Q2 		$5.16M Buy
36,133
+18,349
+103% +$2.62M 0.27% 67
2022
Q1 		$3.06M Buy
17,784
+9,094
+105% +$1.53M 0.16% 133
2021
Q4 		$2.21M Buy
8,690
+4,383
+102% +$1.28M 0.13% 196
2021
Q3 		$1.66M Sell
4,307
-475
-10% -$175K 0.09% 268
2021
Q2 		$1.12M Sell
4,782
-5,297
-53% -$947K 0.06% 464
2021
Q1 		$1.32M Sell
10,079
-3,237
-24% -$469K 0.08% 322
2020
Q4 		$1.39M Sell
13,316
-26,916
-67% -$2.72M 0.1% 241
2020
Q3 		$2.85M Buy
+40,232
New +$2.81M 0.09% 357

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Winton Group's MRNA Position: Q1 2026 in Review

Winton Group sold out of Moderna (MRNA) in Q1 2026, closing a stake of 27,144 shares — an estimated $800K sold.

Winton Group first reported a position in MRNA in Q3 2020 and held it in 16 quarters. The position peaked at $5.16M in Q2 2022. 726 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • Winton Group reported no remaining Moderna position as of Q1 2026 after selling out during the quarter.
  • Winton Group sold 27,144 Moderna shares in Q1 2026, an estimated $800K.
  • Winton Group first reported a position in Moderna in Q3 2020 and held it in 16 quarters.
  • Winton Group's Moderna position peaked at $5.16M in Q2 2022.
  • 726 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Winton Group's 13F filing for Q1 2026, filed 12 May 2026.